Weitman S - Search Results

1

Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft.

Weitman S, Mangold G, Marty J, Dexter D, Hilsenbeck S, Rake J, Juniewicz P, Von Hoff D. Weitman S, et al. Cancer Chemother Pharmacol. 1999;43(5):402-8. doi: 10.1007/s002800050914. Cancer Chemother Pharmacol. 1999. PMID: 10100596

2

Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.

Britten CD, Hilsenbeck SG, Eckhardt SG, Marty J, Mangold G, MacDonald JR, Rowinsky EK, Von Hoff DD, Weitman S. Britten CD, et al. Among authors: weitman s. Cancer Res. 1999 Mar 1;59(5):1049-53. Cancer Res. 1999. PMID: 10070962

3

Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay.

Britten CD, Izbicka E, Hilsenbeck S, Lawrence R, Davidson K, Cerna C, Gomez L, Rowinsky EK, Weitman S, Von Hoff DD. Britten CD, et al. Among authors: weitman s. Cancer Chemother Pharmacol. 1999;44(2):105-10. doi: 10.1007/s002800050953. Cancer Chemother Pharmacol. 1999. PMID: 10412943

4

Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts.

Wadkins RM, Potter PM, Vladu B, Marty J, Mangold G, Weitman S, Manikumar G, Wani MC, Wall ME, Von Hoff DD. Wadkins RM, et al. Among authors: weitman s. Cancer Res. 1999 Jul 15;59(14):3424-8. Cancer Res. 1999. PMID: 10416605

5

The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts.

Weitman S, Marty J, Jolivet J, Locas C, Von Hoff DD. Weitman S, et al. Clin Cancer Res. 2000 Apr;6(4):1574-8. Clin Cancer Res. 2000. PMID: 10778991

6

MGI 114: augmentation of antitumor activity when combined with topotecan.

Weitman S, Barrera H, Moore R, Gonzalez C, Marty J, Hilsenbeck S, MacDonald JR, Waters SJ, Von Hoff D. Weitman S, et al. J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):306-14. doi: 10.1097/00043426-200007000-00006. J Pediatr Hematol Oncol. 2000. PMID: 10959900

7

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model.

Hammond LA, Hilsenbeck SG, Eckhardt SG, Marty J, Mangold G, MacDonald JR, Rowinsky EK, Von Hoff DD, Weitman S. Hammond LA, et al. Among authors: weitman s. Eur J Cancer. 2000 Dec;36(18):2430-6. doi: 10.1016/s0959-8049(00)00302-6. Eur J Cancer. 2000. PMID: 11094320

8

Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).

Hao D, Rizzo JD, Stringer S, Moore RV, Marty J, Dexter DL, Mangold GL, Camden JB, Von Hoff DD, Weitman SD. Hao D, et al. Among authors: weitman sd. Invest New Drugs. 2002 Aug;20(3):261-70. doi: 10.1023/a:1016253716438. Invest New Drugs. 2002. PMID: 12201489

9

Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system.

Diab SG, Hilsenbeck SG, Izbicka E, Weitman SD, Von Hoff DD. Diab SG, et al. Among authors: weitman sd. Anticancer Drugs. 1999 Mar;10(3):303-7. doi: 10.1097/00001813-199903000-00009. Anticancer Drugs. 1999. PMID: 10327037

10

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units.

Petit T, Izbicka E, Lawrence RA, Nalin C, Weitman SD, Von Hoff DD. Petit T, et al. Among authors: weitman sd. Anticancer Drugs. 1999 Mar;10(3):309-15. doi: 10.1097/00001813-199903000-00010. Anticancer Drugs. 1999. PMID: 10327038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters